Concurrently, the YAP/TEAD4–PAI 1 axis and HIF 1α signaling create a hypofibrinolytic milieu, synergizing with tumor-driven platelet activation to favor thrombus persistence [61,62]. The gene discussed is TEAD4; the disease is neoplasm.